CLINICAL_TRIALS
trial_result
· 2017-02-10
Clinical Trial Update: Armodafinil for Patients Starting Hepatitis C Virus Treatment [Phase 4]
Summary
A Phase 4 trial of armodafinil in patients beginning hepatitis C treatment was terminated, with results posted in February 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Research Foundation for Mental Hygiene, Inc. | Conditions: Hepatitis C | Phase 4 | Status: TERMINATED | Results posted: 2017-02-10